A patient with severe, recurrent hypoglycemia and glycemic lability who underwent islet transplantation

Nature Clinical Practice Endocrinology and Metabolism

Volumn 2, Issue 6, 2006, Pages 349-353

  Ryan, Edmond A ^a   Shapiro, A M James ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Glycemic lability; Hypoglycemia; Immunosuppression; Islet transplantation; Type 1 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENALAPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; SIMVASTATIN; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; DIET; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRAFT DYSFUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; MOUTH ULCER; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PERIPHERAL EDEMA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCREENING;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIA; ISLETS OF LANGERHANS TRANSPLANTATION; MIDDLE AGED; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33745071237     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0201     Document Type: Article

References (16)

1. Ryan EA et al. (2004) Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 53: 955-962
2. Pedersen-Bjergaard U et al. (2004) Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 20: 479-486
3. Cryer PE et al. (2003) Hypoglycemia in diabetes. Diabetes Care 26: 1902-1912
4. Gosmanov NR et al. (2005) Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans. Diabetes Care 28: 1124-1131
5. Cryer PE (2004) Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350: 2272-2279
6. Cryer PE (1992) latrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle. Diabetes 41: 255-260
7. Fanelli C et al. (1994) Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 37: 1265-1276
8. Bode B et al. (2004) Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diab Technol Therap 6: 105-113
9. Clarke WL et al. (1995) Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 18: 517-522
10. Ryan EA et al. (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54: 2060-2069
11. Senior PA et al. (2005) Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing. Am J Transplant 5: 2318-2323
12. Cure P et al. (2004) Alterations of the female reproductive system in recipients of islet grafts. Transplantation 78: 1576-1581
13. Hering BJ et al. (2005) Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293: 830-835
14. Fraud T et al. (2005) Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 5: 2037-2046
15. Rickels MR et al. (2005) Islet cell hormonal responses to hypoglycemia after human islet cell transplantation for type 1 diabetes. Diabetes 54: 3205-3211
16. Paty BW et al. (2002) Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 51: 3428-3434